ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE recommends Prevymis on the NHS after re-evaluation
June 05, 2019The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS. -
Merck gears up to file antiviral letermovir in the US, EU
February 28, 2017Merck & Co said it is planning to submit regulatory applications for letermovir in the US and European Union sometime this year, on the back of late-stage data showing its promise in preventing a serious viral infection in patients undergoing a bone marro -
Merck’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) In
February 27, 2017Letermovir Prophylaxis Associated with Lower All-Cause Mortality Through Week 24 Post-Transplant. Company Plans to Submit New Drug Applications for Letermovir in U.S. and EU in 2017.
Pharma Sources Insight January 2025
